Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Neoadjuvant Chemotherapy Versus Upfront Surgery for Locally Advanced Resectable Gall Bladder Cancer : A Randomized Trial

NCT06712420 is registered in ClinicalTrials.gov with Rajiv Gandhi Cancer Institute & Research Center, India as lead sponsor.

NCT NCT06712420
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06712420 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Neoadjuvant Chemotherapy Versus Upfront Surgery for Locally Advanced Resectable Gall Bladder Cancer : A Randomized Trial
Lead sponsor
Rajiv Gandhi Cancer Institute & Research Center, India
Phase
Phase 3
Overall status
Recruiting
Start date
January 1, 2025
Completion date
December 31, 2028
Enrollment
114 (estimated)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

gall bladder carcinoma